Presentation
13 March 2024 Preanalytical optimization of Raman biofluid measurements toward the automation of cancer detection
Author Affiliations +
Abstract
Current diagnostic tumor biopsies are invasive and can disrupt and spread the tumor. Liquid biopsies are inadequate for early-stage detection, resulting in lower survival rates and poorer prognoses. Raman spectroscopy can detect many cancers by identifying subtle cancer-associated metabolites in circulating biofluids. This study investigates preanalytical variables affecting Raman biofluid measurements in head and neck cancer patients, namely spatially correlated changes caused by Marangoni and capillary flow, aiming to streamline testing by reducing sample acquisition time and human intervention. This method is fully automated, providing a high-throughput assay for large-scale screening, paving the way for widely available, sensitive cancer detection.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Rebecca Mayer, Randy Carney, and Kwan Lun Chiu "Preanalytical optimization of Raman biofluid measurements toward the automation of cancer detection", Proc. SPIE PC12850, Optical Diagnostics and Sensing XXIV: Toward Point-of-Care Diagnostics, PC1285007 (13 March 2024); https://doi.org/10.1117/12.3003212
Advertisement
Advertisement
KEYWORDS
Cancer detection

Raman spectroscopy

Automation

Cancer

Tumors

Biopsy

Diagnostics

Back to Top